← Back to Search

1 for Pharmacokinetics

N/A
Waitlist Available
Led By Philip Mathew, MD
Research Sponsored by Intelligent Bio Solutions Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from -1 hr to 24 hrs relative to codeine sulfate dose
Awards & highlights

Summary

This study will compare positive and negative test results obtained from fingerprint sweat using the Intelligent Fingerprinting Drug Screening Cartridge, versus opiates in sweat collected via the Fingerprint Collection Kit for Laboratory Analysis, versus blood, oral fluid and urine sample concentrations of opiates identified within codeine phosphate dosed healthy males and non-pregnant females.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from -1 hr to 24 hrs relative to codeine sulfate dose
This trial's timeline: 3 weeks for screening, Varies for treatment, and from -1 hr to 24 hrs relative to codeine sulfate dose for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Area under the curve (AUC) of codeine in fingerprint sweat, oral fluid, plasma, and urine
Clearance of codeine in fingerprint sweat, oral fluid, plasma, and urine
Maximum concentration (Cmax) of codeine and codeine-6-glucuronide in fingerprint sweat, oral fluid, plasma, and urine
+2 more
Secondary study objectives
Sensitivity of fingerprint sweat screening system for codeine

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Dosed with 3x60mg codeine

Find a Location

Who is running the clinical trial?

Cliantha ResearchOTHER
1 Previous Clinical Trials
321 Total Patients Enrolled
Intelligent Bio Solutions Inc.Lead Sponsor
Philip Mathew, MDPrincipal InvestigatorCliantha Research
~27 spots leftby Sep 2025